Welcome to LookChem.com Sign In|Join Free

CAS

  • or

941711-19-9

1-BOC-4-(2,4-DIFLUOROPHENYL)-4-HYDROXYPIPERIDINE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

941711-19-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 941711-19-9 Structure

  • Basic information

    1. Product Name: 1-BOC-4-(2,4-DIFLUOROPHENYL)-4-HYDROXYPIPERIDINE
    2. Synonyms: 1-BOC-4-(2,4-DIFLUOROPHENYL)-4-HYDROXYPIPERIDINE;1-Boc-4-(2,4-difluorophenyl)-4-piperidinol
    3. CAS NO:941711-19-9
    4. Molecular Formula: C16H21F2NO3
    5. Molecular Weight: 313.342
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 941711-19-9.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 1-BOC-4-(2,4-DIFLUOROPHENYL)-4-HYDROXYPIPERIDINE(CAS DataBase Reference)
    10. NIST Chemistry Reference: 1-BOC-4-(2,4-DIFLUOROPHENYL)-4-HYDROXYPIPERIDINE(941711-19-9)
    11. EPA Substance Registry System: 1-BOC-4-(2,4-DIFLUOROPHENYL)-4-HYDROXYPIPERIDINE(941711-19-9)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 941711-19-9(Hazardous Substances Data)

941711-19-9 Usage

Structure

Cyclic amino alcohol derivative with a piperidine ring

Protecting group

BOC (tert-butyloxycarbonyl) attached to the nitrogen atom

Substituents

a. 2,4-difluorophenyl group
b. Hydroxy group on the piperidine ring

Application

Used in organic synthesis and pharmaceutical research

Purpose

Acts as a building block for the synthesis of potential drug compounds

Importance

Contributes to the development of new pharmaceutical agents

Potential impact

May lead to advancements in medicine and health

Check Digit Verification of cas no

The CAS Registry Mumber 941711-19-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,1,7,1 and 1 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 941711-19:
(8*9)+(7*4)+(6*1)+(5*7)+(4*1)+(3*1)+(2*1)+(1*9)=159
159 % 10 = 9
So 941711-19-9 is a valid CAS Registry Number.

941711-19-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl 4-(2,4-difluorophenyl)-4-hydroxypiperidine-1-carboxylate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:941711-19-9 SDS

941711-19-9Relevant articles and documents

(4-PHENYL-PIPERIDIN-1-YL)-[5-1H-PYRAZOL-4YL)-THIOPHEN-3-YL]-METHANONE COMPOUNDS AND THEIR USE

-

Page/Page column 58, (2011/04/19)

The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain (4-phenyl-piperidin-1-yl)- [5-(1 H-pyrazol-4-yl)-thiophen-3-yl]-methanone compounds that, inter alia, inhibit 11 β-hydroxysteroid dehydrogenase type 1 (11 β-HSD1 ). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit 1 1 β-hydroxysteroid dehydrogenase type 1; to treat disorders that are ameliorated by the inhibition of 11 β-hydroxysteroid dehydrogenase type 1; to treat the metabolic syndrome, which includes disorders such as type 2 diabetes and obesity, and associated disorders including insulin resistance, hypertension, lipid disorders and cardiovascular disorders such as ischaemic (coronary) heart disease; to treat CNS disorders such as mild cognitive impairment and early dementia, including Alzheimer's disease; etc.

DISUBSTITUTED PHENYLPIPERIDINES AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION

-

Page/Page column 28, (2010/11/27)

The present invention relates to compounds of the formulae (4), (5) or (6), and their use in the treatment of central nervous system disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 941711-19-9